Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Koach

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Infection and Immunity|May 24, 2005
Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG aloneD Neil Wedlock, Michel Denis, Margot A Skinner, et al.
Nature Communications|March 26, 2021
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stabilityZsuzsanna Nagy, Janith A Seneviratne, Maxwell Kanikevich, et al.
Molecular Oncology|May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastomaBelamy B Cheung, Owen Tan, Jessica Koach, et al.
Cancers|March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein InterfaceHassina Massudi, Jie-Si Luo, Jessica K Holien, et al.
Oncotarget|July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.
Neoplasia (New York, N.Y.)|June 9, 2021
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53Joanna S Yi, Oscar Sias-Garcia, Nicole Nasholm, et al.
Oncotarget|October 22, 2014
TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cellsSelina K Sutton, Jessica Koach, Owen Tan, et al.
The Journal of Pathology|October 20, 2011
The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitroBelamy B Cheung, Jessica Koach, Owen Tan, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Science Translational Medicine|November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastomaDaniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Infection and Immunity|May 24, 2005
Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG aloneD Neil Wedlock, Michel Denis, Margot A Skinner, et al.
Nature Communications|March 26, 2021
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stabilityZsuzsanna Nagy, Janith A Seneviratne, Maxwell Kanikevich, et al.
Molecular Oncology|May 13, 2015
Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastomaBelamy B Cheung, Owen Tan, Jessica Koach, et al.
Cancers|March 29, 2023
Inhibitors of the Oncogenic PA2G4-MYCN Protein-Protein InterfaceHassina Massudi, Jie-Si Luo, Jessica K Holien, et al.
Oncotarget|July 25, 2016
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4Chengyuan Xue, Denise M T Yu, Samuele Gherardi, et al.
Neoplasia (New York, N.Y.)|June 9, 2021
The synergy of BET inhibitors with aurora A kinase inhibitors in MYCN-amplified neuroblastoma is heightened with functional TP53Joanna S Yi, Oscar Sias-Garcia, Nicole Nasholm, et al.
Oncotarget|October 22, 2014
TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cellsSelina K Sutton, Jessica Koach, Owen Tan, et al.
The Journal of Pathology|October 20, 2011
The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitroBelamy B Cheung, Jessica Koach, Owen Tan, et al.
Cancer Research|September 11, 2019
Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding InterfaceJessica Koach, Jessica K Holien, Hassina Massudi, et al.
Science Translational Medicine|November 6, 2015
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastomaDaniel R Carter, Jayne Murray, Belamy B Cheung, et al.
Pageof 2